Non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukaemia (CLL) Case Study: Efficient Enrolment and Dose Escalation Process Ensures Rapid Access To Critical Data

Non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukaemia (CLL) Case Study: Efficient Enrolment and Dose Escalation Process Ensures Rapid Access To Critical Data